Home Ventilators
Customize your policy alerts
Sign up for Centene Policy CP.MP.184 alerts
Get alerted when Policy CP.MP.184 changes without checking for updates manually.
Monitor payer policy activity
Medical necessity criteria for initial and continued use of noninvasive and invasive home ventilators for non‑Medicare Centene-affiliated plans; who qualifies and documentation/prior authorization expectations.
Clarified initial request is for three months for noninvasive home ventilator use.
Replaced BiPAP failure and contraindication criteria with requirement that member/enrollee could not be appropriately treated with a respiratory assist device (RAD) and that the device will not be used to provide RAD or CPAP therapy.
Added criteria for second/back-up ventilator (noninvasive or invasive) for specific clinical or logistical reasons (e.g., different purposes, wheelchair use, remote residence).
Added HCPCS code E0465 and included descriptions for E0465–E0468.
Coverage Criteria for Home Ventilators
Initial Therapy — Restrictive/Neuromuscular
Covered when ALL of the following are met for initial request (first 3 months):
Initial approval period is 3 months.
Initial Therapy — Severe COPD
Covered when ALL of the following are met for initial request (first 3 months):
Initial approval period is 3 months.
Initial Therapy — Obesity Hypoventilation Syndrome
Covered when ALL of the following are met for initial request (first 3 months):
Initial approval period is 3 months. Polysomnography required to document hypoventilation.
Continuation Therapy
Covered when ALL of the following are met for continued use after initial three-month certification:
Medical director review required for overlap syndromes (e.g., COPD plus sleep apnea).
Invasive Ventilator Criteria
Covered when ALL of the following are met:
Applies to non‑Medicare Centene‑affiliated plans; see corresponding Medicare policy for Medicare members.
Backup Ventilator Coverage
A second or back-up noninvasive or invasive ventilator is considered medically necessary for ANY of the following:
Supportive documentation required to justify medical necessity for a second/back‑up ventilator.
Use of a home ventilator solely to provide respiratory assist device (RAD) or CPAP therapy is excluded under the noninvasive ventilator coverage criteria. The device must be intended to provide ventilatory support (for example, average volume assured pressure support) and the documentation must explicitly state that the noninvasive home ventilator will not be used to provide RAD or CPAP therapy.
Language authorizing ventilator coverage based on prior constructs such as ‘‘BiPAP failure’’ or other BiPAP treatment‑failure formulations has been removed. Requests must now document that the member/enrollee could not be appropriately treated with a respiratory assist device (RAD), and that the noninvasive home ventilator will not be used to provide RAD or CPAP therapy. BiPAP failure is no longer a standalone medical‑necessity criterion.
Coding and Utilization Metrics
| E0465 | Home ventilator, any type, used with invasive interface (e.g., tracheostomy tube). |
| E0466 | Home ventilator, any type, used with noninvasive interface (e.g., mask, chest shell). |
| E0467 | Home ventilator, multi-function respiratory device, also performs functions of oxygen concentration, nebulization, aspiration, and cough stimulation; includes accessories. |
| E0468 | Home ventilator; dual-function respiratory device, also performs additional function of cough stimulation; includes accessories. |
Provider Requirements and Prior Authorization
Prior Authorization Required — Timeframe & Continued-Use
Prior authorization is required for initial requests and is issued for the first three months of noninvasive home ventilator (NIV) use. Continued authorization beyond the initial three-month period requires documentation demonstrating ongoing benefit and continued medical necessity.
- Initial authorization period: 3 months
- Continuation requires documentation of ongoing benefit and at-home use (see documentation callout)
Required Clinical Documentation
Submit clinical documentation with every prior authorization request. For initial requests include: diagnosis (e.g., neuromuscular disease, severe thoracic cage abnormality, obesity hypoventilation syndrome, severe COPD), relevant objective testing performed while the member was stable (not in acute respiratory failure), and evidence that a respiratory assist device (RAD) or CPAP would not appropriately treat the member when applicable.
- Arterial blood gas showing PaCO2 ≥ threshold specified in policy for the indication (measured while awake and breathing at baseline or on prescribed O2 as applicable)
- Sleep oximetry showing O2 saturation < 88% for ≥ 5 minutes when required by indication
- Polysomnography documenting sleep-disordered hypoventilation when required (e.g., OHS)
- Documented maximal inspiratory pressure or forced vital capacity when neuromuscular disease is present
- For COPD: baseline awake PaCO2 per policy thresholds
- Documentation that NIV will not be used to provide RAD or CPAP therapy (i.e., will be used to provide average volume assured pressure support)
- For continuation requests: evidence device is used ≥ average 4 hours per 24-hour period and member shows ongoing benefit from therapy
CPAP/RAD Consideration and Exclusion
Prior to initiating NIV, CPAP (or another RAD) must be considered and ruled out when clinically appropriate. If the record does not demonstrate that RAD/CPAP would be insufficient, the request may be denied. Formal testing for CPAP/RAD is not required only when documentation clearly shows sleep apnea is not the predominant cause of the member’s hypoventilation or nocturnal desaturation.
- Record the consideration and ruling out of CPAP/RAD; if CPAP/RAD was trialed, provide results
- If no formal testing, document clinical rationale showing OSA/CSA is not the primary driver of hypercapnia or desaturation
Clinical Background
Respiratory failure may reflect impaired ventilatory (CO2 retention) or oxygenation (hypoxemia) function and can be acute or chronic. Noninvasive ventilation (NIV) delivers positive pressure via noninvasive interfaces (masks, nasal pillows, etc.) to support ventilation in selected acute and chronic respiratory failures and in the home setting can improve symptoms, quality of life, and reduce readmission and mortality. In contrast, invasive ventilation uses an invasive airway (eg, tracheostomy) when airway protection or ventilatory requirements exceed what can be provided noninvasively. The policy requires objective documentation of respiratory impairment (examples include awake PaCO2 ≥ 45 mm Hg for some indications, sleep oximetry with SpO2 <88% for ≥5 minutes, or physiologic measures such as maximal inspiratory pressure or FVC for neuromuscular disease) to support use of a home ventilator.
Definitions
OpenPayer is powered by Trek Health's payer performance platform. Trek continuously ingests, validates, and normalizes Transparency in Coverage data alongside payer policies and other commercial payer data to create a structured payer intelligence foundation. OpenPayer uses this foundation to deliver personalized search results, dynamically generated policy pages, and tailored policy monitoring based on each user's payers, specialties, billing codes, and areas of interest. The same intelligence powers broader payer performance workflows, including reimbursement benchmarking, contract evaluation, payer negotiations, and financial decision-making.